Live Breaking News & Updates on செல் பரிசோதனை இன்க்

Stay updated with breaking news from செல் பரிசோதனை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment


Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach Using RNAscope and Image Analysis for Patient Enrollment
Laboratory Developed Test for Manual and Image Analysis-assisted Pathologist Interpretation
News provided by
Share this article
Share this article
WESTMINSTER, Colo. and CAMBRIDGE, Mass., April 12, 2021 /PRNewswire/  Flagship Biosciences, the leader in data-centric pathology and tissue analysis, and Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced a partnership to use a clinically validated tumor expression assay utilizing RNAscope
® and tissue image analysis. In a poster shared this week at the American Association for Cancer Research (AACR) Annual Meeting 2021, the companies presented data on the validation of a Dickkopf-1 (DKK1) RNAscope chromogenic in situ hybridization (CISH) assay and digital image analysis solution. ....

United States , New Zealand , South Korea , Republic Of Korea , Trevor Johnson , Douglase Onsi , Pamela Curran , Heather Savelle , Michael Kagey , Securities Exchange , Flagship Biosciences Inc , Beigene Ltd , Leap Therapeutics Inc , Cell Diagnostics Inc , Flagship Biosciences , Senior Director , Leap Therapeutics , Advanced Cell Diagnostics , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜீலாந்து , தெற்கு கொரியா ,